Repurposing Antibody-Drug Conjugates for Theranostic Targeting of Nectin-4 and TROP2 in Bladder Cancer. November 5, 2026 When, where, and in whom does recurrence occur after radical cystectomy for ...
The 2026 ESMO annual meeting featured a prostate cancer proffered paper session and a discussant presentation by Dr. Nicholas van As discussing two abstracts “Perioperative apalutamide + ADT with ...
Repurposing and Testing Agents in Hormone-Sensitive Prostate Cancer Within STAMPEDE - Nicholas James
Nicholas James discusses STAMPEDE’s multi-arm, multi-stage design and the STAMPEDE-2 reboot. Following COVID-related delays, STAMPEDE-2 now runs two arms: one testing radiation to all visible lesions ...
Adaptive MR-guided whole-pelvic SBRT with or without focal intraprostatic lesion boost for high-risk localized prostate Cancer: Adverse events and longitudinal quality-of-life outcomes. November 2, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results